Page last updated: 2024-08-24

3-iodobenzylguanidine and candesartan

3-iodobenzylguanidine has been researched along with candesartan in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuda, N; Onose, Y; Sakabe, K; Shinohara, H; Soeki, T; Tamura, Y1
Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Suzuki, T; Takayama, Y; Toyama, T1
Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Sato, Y; Sumino, H; Suzuki, T; Takayama, Y; Toyama, T1

Trials

2 trial(s) available for 3-iodobenzylguanidine and candesartan

ArticleYear
Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction.
    Journal of the American College of Cardiology, 2005, Mar-01, Volume: 45, Issue:5

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cardiac Volume; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Natriuretic Peptide, Brain; Stroke Volume; Tetrazoles; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Function, Left

2005
Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:12

    Topics: 3-Iodobenzylguanidine; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Drug Synergism; Echocardiography; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Spironolactone; Sympathetic Nervous System; Tetrazoles; Ventricular Function, Left; Ventricular Remodeling

2007

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and candesartan

ArticleYear
Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
    Heart and vessels, 2002, Volume: 17, Issue:2

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Creatinine; Echocardiography; Female; Heart; Heart Failure; Humans; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Potassium; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Angiotensin; Renin; Severity of Illness Index; Statistics as Topic; Stroke Volume; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left

2002